Skip to main content
Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0165
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT

Emmaus Life Sciences Revenue

In the year 2024, Emmaus Life Sciences had annual revenue of $16.65M, down -43.73%. Emmaus Life Sciences had revenue of $3.29M in the quarter ending December 31, 2024, a decrease of -53.42%.

Revenue
16.65M
Revenue Growth
-43.73%
P/S Ratio
0.06
Revenue / Employee
475.80K
Employees
35
Market Cap
1.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.65M-12.94M-43.73%
Dec 31, 202329.60M11.21M60.94%
Dec 31, 202218.39M-2.22M-10.77%
Dec 31, 202120.61M-2.56M-11.04%
Dec 31, 202023.17M415.00K1.82%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

Emmaus Life Sciences News

More News